phosphoserine has been researched along with Coronary Artery Disease in 1 studies
Phosphoserine: The phosphoric acid ester of serine.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, S | 1 |
| Liu, W | 1 |
| Zhuo, X | 1 |
| Wang, L | 1 |
| Wang, G | 1 |
| Sun, T | 1 |
| Zhao, Z | 1 |
| Liu, J | 1 |
| Tian, Y | 1 |
| Zhou, J | 1 |
| Yuan, Z | 1 |
| Wu, Y | 1 |
1 other study available for phosphoserine and Coronary Artery Disease
| Article | Year |
|---|---|
The activation of mTOR is required for monocyte pro-inflammatory response in patients with coronary artery disease.
Topics: Coronary Artery Disease; Enzyme Activation; Female; Gene Knockdown Techniques; Humans; Hydroxymethyl | 2015 |